Current status of radiopharmaceutical therapy

SS James, B Bednarz, S Benedict… - International Journal of …, 2021 - Elsevier
In radiopharmaceutical therapy (RPT), a radionuclide is systemically or locally delivered with
the goal of targeting and delivering radiation to cancer cells while minimizing radiation …

Technological development and advances in single-photon emission computed tomography/computed tomography

Y Seo, C Mari, BH Hasegawa - Seminars in nuclear medicine, 2008 - Elsevier
Single-photon emission computed tomography/computed tomography (SPECT/CT) has
emerged during the past decade as a means of correlating anatomical information from CT …

MIRD pamphlet no. 23: quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapy

YK Dewaraja, EC Frey, G Sgouros… - Journal of Nuclear …, 2012 - Soc Nuclear Med
In internal radionuclide therapy, a growing interest in voxel-level estimates of tissue-
absorbed dose has been driven by the desire to report radiobiologic quantities that account …

[图书][B] Encyclopedia of medical devices and instrumentation

JG Webster - 1990 - dl.acm.org
From the Publisher: This objective, referenced collection of over 300 articles will cover every
aspect of medical devices and instrumentation in four volumes, totalling about 3,000 pages …

Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90Y microsphere …

WA Dezarn, JT Cessna, LA DeWerd, W Feng… - Medical …, 2011 - Wiley Online Library
Yttrium‐90 microsphere brachytherapy of the liver exploits the distinctive features of the liver
anatomy to treat liver malignancies with beta radiation and is gaining more wide spread …

Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software

G Sgouros, KS Kolbert, A Sheikh… - Journal of Nuclear …, 2004 - Soc Nuclear Med
Compared with conventional, whole-organ, S-factor-based dosimetry, 3-dimensional (3D),
patient-specific dosimetry better accounts for radionuclide distribution and anatomic patient …

Theranostic radiopharmaceuticals: established agents in current use

JR Ballinger - The British Journal of Radiology, 2018 - academic.oup.com
Although use of the term “theranostic” is relatively recent, the concept goes back to the
earliest days of nuclear medicine, with the use of radioiodine for diagnosis and therapy of …

Scatter modelling and compensation in emission tomography

H Zaidi, KF Koral - European journal of nuclear medicine and molecular …, 2004 - Springer
In nuclear medicine, clinical assessment and diagnosis are generally based on qualitative
assessment of the distribution pattern of radiotracers used. In addition, emission tomography …

Cancer radioimmunotherapy

RM Sharkey, DM Goldenberg - Immunotherapy, 2011 - Future Medicine
Targeting of radionuclides with antibodies, or radioimmunotherapy, has been an active field
of research spanning nearly 50 years, evolving with advancing technologies in molecular …

Accurate dosimetry in 131I radionuclide therapy using patient-specific, 3-dimensional methods for SPECT reconstruction and absorbed dose calculation

YK Dewaraja, SJ Wilderman, M Ljungberg… - Journal of Nuclear …, 2005 - Soc Nuclear Med
131I radionuclide therapy studies have not shown a strong relationship between tumor
absorbed dose and response, possibly due to inaccuracies in activity quantification and …